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Background
Conventional anti retroviral treatment (ART) has been a
core treatment for HIV over the past three decades.
Despite the effectiveness of these drugs, most of them
abide significant drawbacks such as poor bioavailability
and undesirable side effects; thus reducing patient com-
pliance and rendering treatment regime ineffective. This
research work is an attempt to develop a dual pronged
carrier system using gold nanoparticles (GNP) for
increasing effectiveness and sustained drug release of
saquinavir.
Methods
Leaf extract of Azadirachta indica was used as an effi-
cient sink for synthesis of GNPs by microwave assis-
tance. Saquinavir (Saq) was attached onto GNPs that
were pre functionalized by capping polypeptide linkers
of A.indica and characterized by FTIR. Percentage drug
loading efficiency (%DLE) and release kinetics were stu-
died by statistical model dependent method. Biocompat-
ibility of drug nanoparticle conjugate was studied by
MTT assay. Antiviral efficacy was assessed by quantify-
ing aspartic protease of HIV by fluorescence (FRET)
method.
Results
Mono dispersed GNPs (30-40 nm) were synthesized and
found to carry high payloads of saquinavir with %DLE
of 93.6% as analyzed by Transmission electron micro-
scopy and UV Vis spectroscopy respectively. GNP-saq
conjugate demonstrated 16.7% increase in anti viral effi-
cacy as compared to saquinavir alone. The conjugate
showed sustained drug release and followed 1st order
release kinetics at physiological pH (7.2).
Conclusion
Biogenic GNPs serve as a potent candidate for ferrying
high payloads of anti retroviral drugs with increased effi-
cacy and reduced side effects. This approach can help
reduce dosage frequency and improvise treatment strat-
egy against HIV.
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